Evaluation of learning curve with Indocyanine Green (IcG) versus blue dye for sentinel lymph node biopsy in breast cancer

被引：3

作者：

Hounschell, Corey A. ^{[1
]}

Kilgore, Lyndsey J. ^{[1
]}

Pruitt, Peggy ^{[2
]}

Wilder, Chloe ^{[2
]}

Balanoff, Christa R. ^{[1
]}

Wagner, Jamie L. ^{[1
]}

Baker, Jordan ^{[3
]}

Chollet-Hinton, Lynn ^{[3
]}

Larson, Kelsey E. ^{[1
,4
]}

机构：

[1] Univ Kansas, Med Ctr, Dept Surg, 4000 Cambridge St, Kansas City, KS 66103 USA

[2] Univ Kansas, Sch Med, 2146 W 39th Ave, Kansas City, KS 66103 USA

[3] Univ Kansas, Med Ctr, Dept Biostat & Data Sci, 3901 Rainbow Blvd, Kansas City, KS 66103 USA

[4] 10700 Nall Ave, Overland Pk, KS 66214 USA

来源：

AMERICAN JOURNAL OF SURGERY | 2024年 / 227卷

关键词：

Sentinel lymph node; Breast cancer; Isosulfan blue; Methylene blue; Indocyanine green; METHYLENE-BLUE; PRACTICE GUIDELINE; FLUORESCENCE;

D O I：

10.1016/j.amjsurg.2023.10.003

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

Background: Indocyanine green (IcG) is an alternative to isosulfan blue (IB) for sentinel lymph node (SLN) mapping in breast cancer (BC). IcG carries improved cost and safety, but oncologic data upon implementation in practice is limited. We evaluated the learning curve defined as oncologic yield and operative (OR) time for IcG in SLN mapping in BC. Methods: Retrospective review of patients > 18 years with cTis-2 cN0 BC undergoing surgery first with SLN biopsy using IB or IcG. Analysis compared IB versus IcG across three time cohorts. Results: Of 278 patients, 77 received IB and 201 received IcG. OR time was longer for IcG (p = 0.022). There was no difference in oncologic yield between groups (p = 0.35, p = 0.61). Conclusions: Surgeons may be able to safely transition from IB to IcG for patients with early-stage breast cancer undergoing surgery first. Individuals should track their own data to confirm safety of the technique.

引用

页码：218 / 223

页数：6

共 27 条

[1] Diagnostic Performance of Indocyanine Green Plus Methylene Blue Versus Radioisotope Plus Methylene Blue Dye Method for Sentinel Lymph Node Biopsy in Node-Negative Early Breast Cancer [J].

Agrawal, Sanjit Kumar ;

Hashlamoun, Izideen ;

Karki, Banira ;

Sharma, Abhishek ;

Arun, Indu ;

Ahmed, Rosina .

JCO GLOBAL ONCOLOGY, 2020, 6 :1225-1231

[2] A Review of Indocyanine Green Fluorescent Imaging in Surgery [J].

Alander, Jarmo T. ;

Kaartinen, Ilkka ;

Laakso, Aki ;

Patila, Tommi ;

Spillmann, Thomas ;

Tuchin, Valery V. ;

Venermo, Maarit ;

Valisuo, Petri .

INTERNATIONAL JOURNAL OF BIOMEDICAL IMAGING, 2012, 2012

[3] Current controversies in sentinel lymph node biopsy for breast cancer [J].

Allweis, TM ;

Badriyyah, M ;

Bar Ad, V ;

Cohen, T ;

Freund, HR .

BREAST, 2003, 12 (03) :163-171

[4]

[Anonymous], Methylene Blue

[5]

[Anonymous], Isosulfan Blue

[6]

[Anonymous], Indocyanine Green

[7] Learning curve for the detection of axillary sentinel lymph node in breast cancer [J].

Classe, JM ;

Curtet, C ;

Campion, L ;

Rousseau, C ;

Fiche, M ;

Sagan, C ;

Resche, I ;

Pioud, R ;

Andrieux, N ;

Dravet, F .

EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2003, 29 (05) :426-433

[8] Sentinel lymph node biopsy for breast cancer using methylene blue dye manifests a short learning curve among experienced surgeons: a prospective tabular cumulative sum (CUSUM) analysis [J].

East, Jeffrey M. ;

Valentine, Christopher S. P. ;

Kanchev, Emil ;

Blake, Garfield O. .

BMC SURGERY, 2009, 9

[9]

Fancellu A, 2012, TUMORI J, V98, P413, DOI 10.1700/1146.12633

[10] Positive axillary sentinel lymph node: Is axillary dissection always necessary? [J].

Galimberti, Viviana ;

Chifu, Camelia ;

Perez, Suanly Rodriguez ;

Veronesi, Paolo ;

Intra, Mattia ;

Botteri, Edoardo ;

Mastropasqua, Mauro ;

Colleoni, Marco ;

Luini, Alberto ;

Veronesi, Umberto .

BREAST, 2011, 20 :S96-S98

← 1 2 3 →